Novo Nordisk has promoted Eddie Williams to senior VP of biopharmaceuticals in the US.
Williams has been with Denmark-based diabetes specialist Novo since 2006, when he joined as corporate VP, biopharmaceuticals in the US, leading the sales and marketing, business development and new product commercialisation unit.
Prior to this role, he was a VP at Novartis in the US, holding responsibility for the sales, respiratory & dermatology business unit. He has also served in a senior sales role at Pharmacia.
Jesper Hoiland, president of Novo Nordisk Inc, the company’s US affiliate, commented on the impact Williams has had on Novo’s biopharma business in the US.
“That business has flourished under Eddie’s experienced leadership,” said Hoiland. His promotion to senior vice president demonstrates the company’s focus on, and commitment to, our pipeline of life-changing biological therapies.”